论文信息 - Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment - 字舞流文

Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment

M. A. Abdel Wahab | K. A. Abdel Karim | M. M. Mahdy | S. A. Abdel Raouf | L. R. Ezz EI Arab | A. Shehaby | M. Mahdy